Tarsus Pharmaceuticals Inc.
TARS | NASDAQ
$77.46
-$0.63 (-0.81%)
At close: Sep 21, 2026, 4:00 PM ET
$77.46
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 183.64M | 94.82M | 224.95M | 71.66M | 171.33M | 168.13M |
Short-Term Investments | 233.63M | 196.56M | 2.5M | 145.37M | 483K | n/a |
Long-Term Investments | 3.87M | 3M | 631K | 371K | 663K | n/a |
Other Long-Term Assets | 6.4M | 6.09M | 1.51M | 585K | 463K | 81K |
Receivables | 87.11M | 48.06M | 17.71M | 3.58M | 92K | 20K |
Inventory | 4.37M | 2.62M | 3.11M | n/a | n/a | n/a |
Other Current Assets | 560K | n/a | n/a | n/a | n/a | 20K |
Total Current Assets | 522.78M | 356.71M | 256.13M | 225.38M | 175.95M | 170.66M |
Property-Plant & Equipment | 21.75M | 2.87M | 3.35M | 1.53M | 1.83M | 1.24M |
Goodwill & Intangibles | 7.37M | 8.33M | 3.87M | n/a | n/a | n/a |
Total Long-Term Assets | 39.38M | 20.29M | 9.36M | 2.49M | 2.96M | 1.32M |
Total Assets | 562.16M | 376.99M | 265.49M | 227.86M | 178.91M | 171.97M |
Account Payables | 16.39M | 27.74M | 17.77M | 5.5M | 2.86M | 2.24M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 117.5M | n/a | n/a | n/a | 56K | 304K |
Total Current Liabilities | 135.7M | 80.61M | 36.94M | 15.43M | 11.48M | 5.39M |
Long-Term Debt | 83.04M | 71.85M | 29.82M | 19.43M | n/a | n/a |
Other Long-Term Liabilities | -10.6M | n/a | 1.75M | 48K | 114K | 56K |
Total Long-Term Liabilities | 83.04M | 71.85M | 31.57M | 19.53M | 699K | 605K |
Total Liabilities | 218.73M | 152.46M | 68.5M | 34.96M | 12.18M | 5.99M |
Total Debt | 93.64M | 72.45M | 30.22M | 20.21M | 1.89M | 831K |
Book Value | 343.43M | 224.53M | 196.99M | 192.9M | 166.73M | 165.98M |
Book Value Per Share | 8.22 | 5.97 | 6.70 | 7.84 | 8.11 | 8.17 |
Common Stock | 6K | 6K | 5K | 5K | 4K | 4K |
Retained Earnings | -426.63M | -360.21M | -244.66M | -108.76M | -46.67M | -32.85M |
Comprehensive Income | 381K | 179K | -2K | -74K | n/a | n/a |
Shareholders Equity | 343.43M | 224.53M | 196.99M | 192.9M | 166.73M | 165.98M |
Total Investments | 237.5M | 199.56M | 3.13M | 145.74M | 1.15M | n/a |
Add to Watchlist
Select watchlists to add or remove TARS